- Home
- FNWB vs XTNT Comparison
FNWB vs XTNT Comparison
Compare FNWB & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- XTNT
- Stock Information
- Founded
- FNWB 1923
- XTNT N/A
- Country
- FNWB United States
- XTNT United States
- Employees
- FNWB N/A
- XTNT N/A
- Industry
- FNWB Banks
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNWB Finance
- XTNT Health Care
- Exchange
- FNWB Nasdaq
- XTNT Nasdaq
- Market Cap
- FNWB 95.2M
- XTNT 83.2M
- IPO Year
- FNWB 2015
- XTNT N/A
- Fundamental
- Price
- FNWB $10.76
- XTNT $0.59
- Analyst Decision
- FNWB Hold
- XTNT Strong Buy
- Analyst Count
- FNWB 1
- XTNT 1
- Target Price
- FNWB $12.00
- XTNT $3.00
- AVG Volume (30 Days)
- FNWB 31.6K
- XTNT 50.3K
- Earning Date
- FNWB 01-29-2025
- XTNT 03-31-2025
- Dividend Yield
- FNWB 2.60%
- XTNT N/A
- EPS Growth
- FNWB N/A
- XTNT N/A
- EPS
- FNWB N/A
- XTNT N/A
- Revenue
- FNWB $50,900,000.00
- XTNT $113,862,000.00
- Revenue This Year
- FNWB N/A
- XTNT $31.27
- Revenue Next Year
- FNWB $11.60
- XTNT $13.07
- P/E Ratio
- FNWB N/A
- XTNT N/A
- Revenue Growth
- FNWB N/A
- XTNT 45.11
- 52 Week Low
- FNWB $8.91
- XTNT $0.33
- 52 Week High
- FNWB $16.00
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- FNWB 46.62
- XTNT 52.36
- Support Level
- FNWB $10.80
- XTNT $0.55
- Resistance Level
- FNWB $12.10
- XTNT $0.62
- Average True Range (ATR)
- FNWB 0.33
- XTNT 0.05
- MACD
- FNWB -0.03
- XTNT -0.01
- Stochastic Oscillator
- FNWB 7.59
- XTNT 41.76
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.